formats

Incyte-Merck trial fails in blow to cancer immunotherapy, but researchers remain hopeful

Cancer researchers believe immunotherapy still holds potential for patients.

All rights reserved to: UIG | United Investment Group 2012 , Powered By: UCG.ae